Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
The NAMO Effect
The Namo government has not really wooed the pharma sector in it's first tenure. Despite some significant measures, the industry…
HC restrains ex-Ranbaxy promoters from selling assets till Feb 26
The court also directed the brothers and 12 others, including their family members and companies, to come up with a plan on how…
DRL’s Chairman, COO added as defendants in US lawsuit
The lawsuit filed at the District Court for New Jersey seeks damages to compensate the class of investors for a 'purported…
NATCO Pharma undergoes API facility inspection by US FDA
The regulatory audit resulted in zero observations and no Form 483 was issued
amfAR renews investment in bioengineering approaches to curing HIV
Totalling nearly $1 million, the investment grants will allow two collaborative teams of HIV researchers and bioengineers to…
Glenmark Pharma presents new data on GBR 830
The first-in class, investigational, anti-OX40 monoclonal antibody is indicated for the treatment of moderate-to-severe atopic…
APICS, IMA release report on supply chain management
The new report offers solution to widespread costing failures
GSK receives European approval for Influenza vaccine
The drug will be able to treat both adults and children from six months of age
Mosquito gut may hold the key to preventing dengue and zika
The study describes the first comprehensive analysis of the Aedes aegypti midgut